An alternative chemical that can reprogram cancer cells to DIE:
Anyway, you’ve learned more about DCA than you care to, or need to, know. That’s because there is another small molecule that deserves more attention. Like DCA, it is a small molecule that can enter the cell nucleus and switch genes on or off. It is perceived by the body as a toxin, but actually is non-toxic, and it is very stealth, it can penetrate any resistant cancer cell. It works in a similar manner to DCA by inducing cancer cell death (apoptosis). The molecule is resveratrol, known as a red wine molecule. Resveratrol appears to kill off cancer cells by depolarizing (demagnetizing) mitochondrial bodies within tumor cells.
Resveratrol is 100 anti-cancer drugs in one. Resveratrol works in so many ways to block cancer, researchers can’t find a cancer-promotion pathway it doesn’t inhibit. It is virtually non-toxic since, after oral ingestion, it is quickly metabolized by the liver, attached to a detoxification molecule called glucuronate, which renders it harmless, though biologically inactive, at least for a time.
At the site of tumors cells there is an unzipping enzyme (glucuronidase) that uncouples resveratrol from glucuronate. This is nature’s "drug delivery system," releasing resveratrol at the right time and place. This explains resveratrol’s stealthiness. [Cancer Letters 231: 113–22, 2006; Oncogene 23: 6702–11, 2004; Toxicology Letters 161: 1–9, 2006; World Journal Gastroenterology 12: 5628–34, 2006; Investigative Ophthalmology Visual Science 47: 3708–16, 2006; Cancer Detection Prevention 30: 217-23, 2006; Molecular Cancer Therapy 4: 554–61, 2005; Journal Biological Chemistry 278: 41482–90, 2003]
There are currently two human resveratrol/cancer trials underway, one for cancer prevention at the University of Leicester, and one for colon cancer at the University of California, Irvine. Both trials have passed the safety arm, meaning no overt toxicity. Cancer patients await the completion of these studies.
Source:
http://www.lewrockwell.com/sardi/sardi68.html
Caveat: The writer has a vested interest in resveratrol pills but it's definitely a good place for further research, vested interest notwithstanding.